| As of Date | 03/31/2026 |
| Registration | SEC, Approved, 07/30/2021 |
|
|
|
| Former registrations | |
| ADV Location | NEW YORK, NY, United States |
| Contact Info | 410 xxxxxxx |
| Websites |
| AUM* | 2,176,631,478 98% |
| of that, discretionary | 1,926,997,093 75% |
| Private Fund GAV* | 1,614,557,903 26% |
| Avg Account Size | 65,958,530 2% |
| SMA’s | No |
| Private Funds | 46 19 |
Number of Employees 30 -14%
of those in investment advisory functions 13 -19%
- Investment companies
- Pooled investment vehicles
- Pension and profit sharing plans
- Charitable organizations
- Other investment advisers
- Corporations or other businesses not listed above
- Other
- Portfolio management for investment companies
- Portfolio management for pooled investment vehicles
- Portfolio management for businesses
- A percentage of assets under your management
- Performance-based fees
| SEC Fund Type | Count | GAV |
|---|---|---|
| Fund TypeHedge Fund | Count5 | GAV$161,617,092 |
| Fund TypePrivate Equity Fund | Count8 | GAV$756,122,642 |
| Fund TypeVenture Capital Fund | Count28 | GAV$405,767,448 |
| Fund TypeOther Private Fund | Count5 | GAV$291,050,721 |
| Adviser | Hedge Fund | Liquidity Fund | Private Equity Fund | Real Estate Fund | Securitized Asset Fund | Venture Capital Fund | Other Fund | Total Private Fund GAV | AUM | #Funds | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Adviser TRIBE CAPITAL | Hedge Fund- | Liquidity Fund- | Private Equity Fund550.7m | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund4.6b | Other Fund105.3m | Total Private Fund GAV9.9b | AUM3.4b | #Funds139 | |
| Adviser INDIGO PARTNERS LLC | Hedge Fund- | Liquidity Fund- | Private Equity Fund606.3m | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund1.8b | Other Fund33.7m | Total Private Fund GAV4.3b | AUM1.7b | #Funds21 | |
| Adviser MPM BIOIMPACT | Hedge Fund657.1m | Liquidity Fund- | Private Equity Fund- | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund1.1b | Other Fund1.7b | Total Private Fund GAV4.5b | AUM3.6b | #Funds25 | |
| Adviser MANHATTAN WEST ASSET MANAGEMENT, LLC | Hedge Fund- | Liquidity Fund- | Private Equity Fund202.8m | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund1.6b | Other Fund84.5m | Total Private Fund GAV3.4b | AUM1.2b | #Funds87 | |
| Adviser ALPHA SQUARE GROUP S, LLC | Hedge Fund- | Liquidity Fund- | Private Equity Fund234.1m | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund1.1b | Other Fund243.1m | Total Private Fund GAV2.7b | AUM1.6b | #Funds35 | |
| Adviser ROSECLIFF VENTURE MANAGEMENT, LLC | Hedge Fund- | Liquidity Fund- | Private Equity Fund137.3m | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund512.5m | Other Fund26.1m | Total Private Fund GAV1.2b | AUM649.8m | #Funds15 | |
| Adviser VILLAGE GLOBAL MANAGEMENT, L.L.C. | Hedge Fund- | Liquidity Fund- | Private Equity Fund46.2m | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund836.1m | Other Fund- | Total Private Fund GAV1.7b | AUM978.7m | #Funds9 | |
| Adviser SUMMIT PEAK INVESTMENTS, LLC | Hedge Fund- | Liquidity Fund- | Private Equity Fund13.3m | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund1.4b | Other Fund- | Total Private Fund GAV2.8b | AUM1.1b | #Funds44 | |
| Adviser CORNER CAPITAL MANAGEMENT, LLC | Hedge Fund- | Liquidity Fund- | Private Equity Fund204.1m | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund585.3m | Other Fund134.9m | Total Private Fund GAV1.5b | AUM787.4m | #Funds39 | |
| Adviser NEXT COAST VENTURES, LLC | Hedge Fund- | Liquidity Fund- | Private Equity Fund- | Real Estate Fund- | Securitized Asset Fund- | Venture Capital Fund- | Other Fund- | Total Private Fund GAV- | AUM583.0m | #Funds- |
| Stock Ticker | Stock Name | $ Position | % Position | $ Change | # Change |
|---|---|---|---|---|---|
| Stck Ticker252828108 | Stock NameDIANTHUS THERAPEUTICS INC | $ Position$47,021,047 | % Position10.00% | $ Change75.00% | # Change-14.00% |
| Stck Ticker10806X102 | Stock NameBRIDGEBIO PHARMA INC | $ Position$32,081,360 | % Position7.00% | $ Change | # Change |
| Stck Ticker04351P101 | Stock NameASCENDIS PHARMA A/S | $ Position$29,531,559 | % Position6.00% | $ Change16.00% | # Change8.00% |
| Stck Ticker110122108 | Stock NameBRISTOL-MYERS SQUIBB CO | $ Position$25,517,093 | % Position5.00% | $ Change-27.00% | # Change-35.00% |
| Stck Ticker375558103 | Stock NameGILEAD SCIENCES INC | $ Position$22,843,440 | % Position5.00% | $ Change-36.00% | # Change-43.00% |
| Stck Ticker87164F105 | Stock NameSYNDAX PHARMACEUTICALS INC | $ Position$24,380,131 | % Position5.00% | $ Change-3.00% | # Change-13.00% |
| Stck Ticker880881107 | Stock NameTERNS PHARMACEUTICALS INC | $ Position$21,564,114 | % Position5.00% | $ Change290.00% | # Change199.00% |
| Stck Ticker24477V105 | Stock NameDEFINIUM THERAPEUTICS INC | $ Position$19,617,898 | % Position4.00% | $ Change | # Change |
| Stck Ticker101137107 | Stock NameBOSTON SCIENTIFIC CORP | $ Position$18,782,205 | % Position4.00% | $ Change-45.00% | # Change-17.00% |
| Stck Ticker45337C102 | Stock NameINCYTE CORP | $ Position$17,139,346 | % Position4.00% | $ Change | # Change |